Sigma's Share-Price Wobble Drives Renewed Bullishness -- Market Talk

Dow Jones
04/13

0226 GMT - Sigma Healthcare's recent share-price weakness only makes Morgans analyst Scott Power more bullish on the stock. Raising his recommendation on the Australian pharmaceutical wholesaler and retailer to buy from accumulate, Power tells clients in a note that he continues to anticipate annual earnings growth of about 20% over the next three years. He expects like-for-like sales growth, new domestic and international stores, operating efficiencies and the eventual delivery of A$100 million in annual synergies from 2025's merger between Sigma and the Chemist Warehouse retail chain. Morgans maintains its target price at A$3.36. Shares are down 0.7% at A$2.67. (stuart.condie@wsj.com)

 

(END) Dow Jones Newswires

April 12, 2026 22:26 ET (02:26 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10